Abemaciclib 150 mg Tablet – Breast Cancer Treatment

Abemaciclib 150 mg Tablets is a targeted anti-cancer medication used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. It belongs to the class of CDK4/6 inhibitors, which help block cancer cell growth and division.

It is commonly prescribed alone or in combination with hormone therapy such as fulvestrant or aromatase inhibitors to improve survival outcomes.

⚙️ How Abemaciclib Works

Abemaciclib works by:

• Inhibiting Cyclin-Dependent Kinases 4 and 6 (CDK4/6)

• Stopping cancer cell cycle progression

• Slowing tumor growth and spread

• Enhancing effectiveness of hormone therapy

🩺 Uses of Abemaciclib 150 mg Tablets

• HR-positive, HER2-negative breast cancer

• Advanced or metastatic breast cancer

• Breast cancer resistant to hormone therapy

• Combination therapy with endocrine treatments

💡 Benefits of Abemaciclib 150 mg

• Slows cancer cell growth

• Improves progression-free survival

• Effective oral targeted therapy

• Reduces tumor progression risk

• Suitable for long-term cancer management

📌 Dosage & Administration

• Usually taken twice daily or as prescribed

• Can be taken with or without food

• Swallow tablet whole — do not crush

• Dose adjustments based on tolerance and side effects

⚠ Follow oncologist instructions strictly.

⚠️ Possible Side Effects

• Diarrhea

• Fatigue

• Nausea or vomiting

• Loss of appetite

• Low white blood cell count

• Liver enzyme changes

Seek medical help if severe symptoms occur.

🚫 Precautions & Warnings

• Prescription-only oncology drug

• Monitor blood counts and liver function

• Avoid during pregnancy and breastfeeding

• Inform doctor about liver or kidney issues

• Use effective contraception during treatment

🏥 Storage Instructions

• Store below 25°C

• Keep away from heat and moisture

• Keep out of reach of children

📦 Packaging Details

• Strength: 150 mg

• Dosage Form: Film-Coated Tablet

• Manufacturer: Lilly

• Pack Size: 7×2 Tablets